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Abstract 
Background: The search for new antimicrobial compounds able to overcome the global issue of microbial resistance 
to antibiotics is a priority worldwide. Moreover, several commensal microorganisms have been increasingly associated 
to opportunistic microbial infections. Having previously disclosed the green synthesis and preliminary characteriza‑
tion of the oligomers [linear oligo(ethylenimine) hydrochloride and oligo(2‑methyl‑2‑oxazoline) quaternized with N,N‑
dimethyldodecylamine] we herein report on the screening of these oligomers against a battery of 69 clinical isolates 
of Aerococcus spp., Candida spp., Staphylococcus spp. and Streptococcus spp.
Findings: The isolates’ susceptibility to both oligomers was evaluated by determining their minimal inhibitory con‑
centration (MIC) and the biocidal effectiveness of each compound was further confirmed through spectrophotomet‑
ric measurements and fluorescence microscopy. The MIC values of the 69 isolates were highly variable, yet favourably 
comparable with those of other antimicrobial polymers. The viability assays resulted in 100% of microbial killing rate 
after only 5 min, highlighting the promising antimicrobial action of these oligomers.
Conclusions: Though further studies are required, evidence suggests that a strong effort should be done in order 
to confirm these compounds as valid alternatives for several clinical applications. This is reinforced by their well 
described biocompatibility with human tissues and by their proposed mechanism of action which difficult the devel‑
opment of microbial resistance to these compounds.
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Findings
Oxazoline‑based polymers
Microbial resistance to antibiotics is recognized as a 
major public health issue that urges rapid and effective 
resolution (Alanis 2005). This triggered the increasing 
attention that has been given to the search for alterna-
tive antimicrobial agents with higher effectiveness and 
with less risk for the development of similar resist-
ance in a medium/long term (Aiello and Larson 2003; 
Hoogenboom 2009; Kenawy et al. 2007). In this context, 
polymeric antimicrobial materials have been recently 
considered as valuable alternatives to conventional anti-
biotics (especially as a preventive barrier for topical 
application and as coatings for critical surfaces), lead-
ing several authors to revisit poly(oxazoline)s potential 
after several decades of hiatus on their research (de la 
Rosa 2013; Kenawy et al. 2007; Hoogenboom 2009). The 
structural and functional characteristics of polymeric 
oxazolines, namely chemical stability, reduced toxicity, 
non-volatility properties, restricted permeation through 
the skin and potential as antimicrobial agents, turns them 
as promising alternatives to other well-known polymers 
already used in biomedical applications, such as e.g. poly-
ethylene glycol (PEG) (de la Rosa 2013).
Even though the mechanism of action of these poly-
mers remains unknown, it is thought to be identical to 
that of poly(peptides) (Waschinski et al. 2008). In a brief 
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overview, it is hypothesised that poly(peptides) attach to 
the bacterial surface and cross the outer membrane of 
Gram-negative cells, or the thick layer of Gram-positive 
cells, by a self-promoted uptake to reach the anionic 
surface of the cytoplasmic membrane (Hancock and 
Sahl 2006). Finally, peptides disrupt the cell membrane 
by forming pores (barrel-stave model or toroidal-pore 
model) or by accumulating on the bilayer surface, cover-
ing it, dissolving the membrane in a detergent-like mode 
(carpet model) (Brogden 2005). Thus, poly(oxazoline)s 
are thought to present selectivity to negatively charged 
microbial cell envelopes relatively to the neutral mamma-
lian cytoplasmic membranes, as occurs in poly(peptides) 
(Hancock and Sahl 2006). Consequently, poly(oxazoline)
s are believed to be less susceptible to microbial resist-
ance when compared to conventional antibiotics because 
it would imply a complete remodelling of the structure of 
the cellular membrane (Zasloff 2007).
Green functionalized oligomers
An innovative green methodology (supercritical car-
bon dioxide technology) has been recently used by 
Aguiar-Ricardo and collaborators, aiming the devel-
opment of sustainable and environmental friendly 
approaches to synthesize promising new functionalized 
oligo(oxazolines) (Correia et  al. 2011; de Macedo et  al. 
2007). In previous work, the synthesis, chemical char-
acterization, cytotoxicity and preliminary investigation 
of their potential as antimicrobial agents against the 
reference strains Escherichia coli AB1157 and Staphylo-
coccus aureus NCTC8325-4 were undertaken (Correia 
et al. 2011). From a large set of preliminarily tested com-
pounds, the two most promising were selected to be fur-
ther investigated as antimicrobial agents against clinical 
isolates: linear oligo(ethylenimine) hydrochloride (here-
after defined as LOEI) and oligo(2-methyl-2-oxazoline) 
quaternized with N,N-dimethyldodecylamine (hereafter 
defined as OMETOX-DDA). These two oxazoline-based 
oligomers were obtained by cationic ring opening polym-
erization (CROP) in supercritical carbon dioxide which 
presents several advantages comparatively to conven-
tional synthetic routes using organic solvents (see Sup-
plementary Information for details on the synthesis and 
chemical characterization of the oligomers) (Correia 
et al. 2011). Among them, oligomers intrinsic blue fluo-
rescence (Bonifácio et  al. 2012), well-defined degrees of 
polymerization (generally are small polymers, oligom-
ers), low polydispersity, high purity avoiding extensive 
purification in the end of the procedure are very impor-
tant features when envisaging biomedical applications as, 
for example, 3D structures modification to confer anti-
microbial and self-desinfection properties (Correia et al. 
2013). This work acts as a follow-up study of Correia 
et al. (2011), expanded the antimicrobial efficiency of the 
selected oligomers against clinical isolates. Therefore, a 
susceptibility testing program against a battery of clinical 
isolates belonging to some relevant pathogenic taxa was 
conducted using well established methodologies (CLSI 
2014), and fluorescence based viability tests were used on 
four of the isolates to confirm the biocidal effect of the 
compounds.
Antimicrobial activity against clinical isolates
The strains tested in this study were previously isolated 
from clinical samples (Martins 2012) and are property of 
the Instituto Superior de Ciências da Saúde Egas Moniz. 
The selected strains comprise a total of 69 belonging 
to Aerococcus spp., Candida spp., Staphylococcus spp. 
and Streptococcus spp. These are Gram-positive aero-
bic and facultative anaerobic strains, tested due to the 
growing interest on studying the susceptibility of such 
microorganisms to alternative antimicrobials, since 
they are major colonizers of several human tissues (e.g. 
skin, mouth and respiratory tract) that frequently cause 
opportunistic infections (Alanis 2005; Miceli et al. 2011).
The MIC (90% of inhibition) values were obtained 
following the standard methodology implemented by 
the Clinical and Laboratory Standards Institute (CLSI 
2014) using twofold dilutions from 6,240 to 6  µg  mL−1 
in Mueller-Hinton Broth (MHB) medium. Positive and 
negative controls were undertaken in parallel with the 
tests, consisting respectively in (1) MHB inoculated with 
the respective tested microorganism (no oligomer) and 
(2) three different dilutions of the oligomers in MHB 
medium and also only MHB to assure sterility (no inocu-
lation in both negatives). Additionally, the full taxonomic 
details of each isolate, respective result on the MIC values 
and standard deviation are displayed in Additional file 1: 
Table S1, revealing high variability of MICs between and 
within taxa. An overview of the obtained MIC values is 
depicted in Fig.  1, which exposes important differences 
when comparing the means of both oligomers at the four 
taxa. Candida spp., Staphylococcus spp. and Streptococ-
cus spp showed significant higher susceptibility to LOEI 
than to OMETOX-DDA (p value <0.05). Aerococcus spp. 
displayed similar means of MIC values to both oligomers. 
Importantly, LOEI shows an overall stronger inhibitory 
effect than OMETOX-DDA, except against Aerococ-
cus spp. This variability in MIC values is not surprising 
when considering previous reports on the differences of 
susceptibility to drugs between different types of micro-
organisms, mostly related with their differences in the 
thickness of the peptidoglycan layer of the cell membrane 
and their cell wall structures, which are variable within 
different strains of the same species (Timofeeva and Kle-
shcheva 2011).
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Following the results obtained in MIC determination 
one strain of Aerococcus urinae (facultative pathogen, 
colonizer of urinary tract), Candida albicans (represent-
ing pathogenic yeasts), Staphylococcus aureus (one of the 
most studied opportunistic pathogens, major colonizer of 
the skin and mucosa) and Streptococcus mutans (mutans 
streptococci, responsible for caries and oral infections) 
were submitted to viability assays using a concentration 
of fivefold the established MIC in MHB media for each 
of the tested strain (bolded in Additional file  1: Table 
S1). The media also contained propidium iodide (PI) 
labelling to allow measuring the fluorescence emissions 
along time, indicative of death by membrane disruption 
and hybridization of PI with nucleic acids. Aliquots were 
removed at 5 and at 30 min, washed with saline solution 
to remove any excess of propidium iodide and observed 
with a DM5500 B fluorescence microscope (Leica) using 
a N21 filter set, a 100× magnification objective and 
images  were captured with an Andor Luca R EMCCD 
camera. Additionally, similar aliquots were also plated in 
solid media to confirm microbial death. Positive (stand-
ard cultivation in MHB without any oligomer but with PI 
labelling) and negative (MHB with no cells) controls were 
undertaken for all these procedures.
In Fig. 2 it is possible to observe significant increasing 
of fluorescence emission (p value <0.05) after one single 
minute of action and then a slight increase after 5  min 
followed by an overall stabilization of the emissions till 
the final time point at 30  min. The statistical analysis 
(Mann–Whitney and t tests) revealed that the increase 
on fluorescence emission was significant relatively to the 
positive controls during the whole experiment (p values 
<0.05).
When comparing the results in the present work with 
the preliminary assays undertaken with reference strains 
(Correia et  al. 2011), we noticed some interesting dif-
ferences in the time of death. With reference strains the 
oligomer 5 (LOEI in this work) took ca. 75  min to kill 
E. coli and 4 h to effectively kill S. aureus cells contrast-
ing with the 5  min necessary to achieve bacterial kill 
reported herein; however, in that work the oligomer 1b 
(OMETOX-DDA in this work) revealed similar results 
to those obtained in the present contribution, killing 
bacterial cells after 5 min of incubation. In Correia et al. 
(2011) the differences in time of action between the two 
oligomers were assumed to be a consequence of distinct 
mechanisms (described above). However the shorter kill-
ing times herein verified with LOEI suggests that the use 
of a concentration fivefold higher than the MIC values 
Fig. 1 Bar chart containing the means of the MIC values (90% of 
inhibition) obtained for the four tested genus. Significant differences 
between the overall MICs of the two oligomers in each genus are 
marked with asterisks.
Fig. 2 Plots of the fluorescence emission of four different clinical isolates when in contact with a LOEI and b OMETOX‑DDA. Statistically significant 
differences relatively to the control were detected in fluorescence emission at all measured time points for all the tested strains (marked with aster-
isks), with the exception of time 0.
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provides effective and quick killing of clinical isolates, 
contrasting with reference strains, illustrated by fluores-
cence microscopy micrographs (Fig.  3) and confirmed 
using plate inoculation after 5 and 30  min in contact 
with the two compounds, which retrieved no micro-
bial growth in solid media, in contrast with the normal 
growth obtained for positive control. This emphasizes 
the potential of both oligomers as powerful biocidal 
agents against both yeasts and bacteria, which is probably 
related to the negatively charged cell wall of both groups 
of microorganisms (Ibeas et al. 2000).
Importantly, these compounds have previously shown 
selectivity towards microbial cells. Correia et al. observed 
that their bactericidal activity is much faster than their 
cytotoxic effect in mammalian cells, as the latest are 
still metabolically active after 42  h in the presence of 
0.1 mg mL−1. In that work, metabolic decay was observed 
in mammalian cells after 48  h using concentrations 
around 10 mg mL−1 (Correia et al. 2011). Thus, both con-
centrations and time of exposure largely exceed the MIC 
values that they established for reference strains. Similar 
analysis can be inferred in this work having as basis the 
cytotoxicity tests undertaken by Correia et al. since that 
the kinetics of antibacterial activity are so fast (compared 
to the time it takes for mammalian toxicity to occur) that 
there is a therapeutic window for the application of these 
oligomers, even if the concentrations used during the via-
bility assays were fivefold of the established MIC for each 
strain, thus approaching to the toxic level to mammalian 
cells (10 mg mL−1). This opens the door for future studies 
due to their slow onset of toxicity, still our data revealed 
that these oligomers will hardly become suitable for pro-
longed application and/or contact time.
Despite the fact that the used concentrations in this 
work may look extremely high, especially if compared 
with standard antibiotics, such comparison should be 
performed with chemicals presenting similar chemical 
properties and/or mechanism of action. Most of the con-
ventionally used antibiotics act mostly as metabolic and/or 
protein synthesis inhibitors (e.g. ampicillin and rifampicin) 
and are commonly used for the treatment of systemic 
infections. Due to their mechanism of action, small size 
and molecular weight, the oligomers described herein 
might be comparable with other antimicrobial polymers, 
Fig. 3 Illustrative micrographs of the fluorescence microscopy analysis exposing the microbiocidal activity of the tested compounds. For each 
compound a control, b LOEI and c OMETOX‑DDA) the total community is depicted in the left column (contrast‑phase microscopy) and the death 
cells are observable in red (propidium iodide) in the right column.
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with conventional antimicrobial peptides (AMP’s) or even 
with new classes of rare and cryptic secondary metabo-
lites, such as peptaibols (Duclohier 2010). A closer look 
to the literature reveals that several of these compounds 
reported antimicrobial activity at concentrations closer to 
10  mg  mL−1 such as e.g. protamine, a well known AMP 
(Aspedon and Groisman 1996). Such values are considera-
bly higher than the ones considered in the present work, so 
we can state that when compared to similar chemicals with 
similar antimicrobial mechanisms, the oligomers studied 
herein present encouraging results (de la Rosa 2013).
Of relevance is also the sustainable and environmental 
friendly approach used for the synthesis of these com-
pounds constituting an important advance due to the 
increasing concerns regarding the environmental safety 
during the production of new synthetic antimicrobials 
(Martinez 2009).
The evaluation of the biocidal potential of these two 
functionalized oligomers against a wide range of clinical 
isolates demonstrated therapeutic potential. Neverthe-
less, further in  vitro preclinical testing is needed before 
these compounds can be scaled up to multi-gram lev-
els for in vivo evaluation. We believe that investigations 
exploring the action of these oligomers against clinical 
isolates of Gram-negative, enteric and anaerobic micro-
organisms should also be soon conducted.
This work confirms the promising potential of both oxa-
zoline based oligomers against clinical isolates, and empha-
sises that the development and improvement of this class 
of materials may help solving some current issues in terms 
of epidemiology (de la Rosa 2013). The chemical and anti-
microbial properties of these oligomers open the door for 
future topical and antimicrobial coating applications (de la 
Rosa 2013), strategies in line with a preventive philosophy 
as the first line of defence against microbial infections.
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